Provided by Tiger Trade Technology Pte. Ltd.

Adamis Pharmaceuticals

0.7751
0.0000
Volume:- -
Turnover:92.68K
Market Cap:7.25M
PE:-0.07
High:0.7751
Open:0.7751
Low:0.7751
Close:0.7751
52wk High:26.18
52wk Low:0.7500
Shares:9.36M
Float Shares:9.15M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.2445
EPS(LYR):-12.3688
ROE:-784.96%
ROA:-104.49%
PB:-0.61
PE(LYR):-0.06

Loading ...

Company Profile

Company Name:
Adamis Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injectable pre-filled single dose syringe products for use in the emergency treatment of acute allergic reactions comprising anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company was founded in 2006 and is headquartered in San Diego, California.